EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Two-Stage Constrained Model Selection and Cost-Sensitive Threshold Control for Explainable Diabetes Readmission Prediction

Aminu Usman Jibril, A. Senthil Kumar, Imran Dauda Aliyu

Advances in Precision Medicine · 09.11.2026 · 11 (7) · 176-202

DOI: 10.26689/apm.v11i7.16183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Precision Medicine, online erschienen am 09.11.2026. Verfasst von Aminu Usman Jibril und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Model architecture and decision threshold jointly determine the behavior of a clinical prediction system. This study presents two complementary analyses of diabetes readmission prediction. Stage 1 applies Pareto enumeration, an area under the receiver operating characteristic curve (AUROC) tolerance, normalized utility, a worst-objective regret diagnostic, and 100,000 preference-weight simulations to five candidates with complete reported metrics. Stage 2 examines archived results for seven classifiers and explores calibration and cost-sensitive threshold selection for a separately refitted stack. In Stage 1, XGBoost and stacking were non-dominated; an absolute AUROC tolerance of 0.0005 selected XGBoost, which maximized utility in 99.88% of five-objective weight draws. In Stage 2, the stack achieved AUROC 0.70349 and average precision 0.66796. Platt scaling marginally reduced the refitted stack’s Brier score from 0.217859 to 0.217845. With illustrative false-negative and false-positive costs of 5,000 and 1,000 units, the test-grid minimum occurred at 0.20. Relative to 0.50, recall increased from 0.56475 to 0.99519 and total cost fell by 56.28%; however, 96.66% of encounters were flagged, and cost was only 3.74% lower than flagging all encounters. Shapley additive explanations (SHAP) described the individual LightGBM model. Preprocessing before splitting, encounter-level partitioning, test-informed calibration and threshold selection, and unresolved cohort provenance limit inference. The framework makes selection preferences and operating trade-offs explicit, but requires a locked, patient-separated evaluation before clinical use.

Zitieren

APA

Jibril, A. U., Kumar, A. S., & Aliyu, I. D. (2026). Two-Stage Constrained Model Selection and Cost-Sensitive Threshold Control for Explainable Diabetes Readmission Prediction. Advances in Precision Medicine, 11(7), 176-202. https://doi.org/10.26689/apm.v11i7.16183

Vancouver

Jibril AU, Kumar AS, Aliyu ID. Two-Stage Constrained Model Selection and Cost-Sensitive Threshold Control for Explainable Diabetes Readmission Prediction. Advances in Precision Medicine. 2026;11(7):176-202. doi:10.26689/apm.v11i7.16183

BibTeX
@article{Jibril2026,
  author = {Jibril, Aminu Usman and Kumar, A. Senthil and Aliyu, Imran Dauda},
  title = {Two-Stage Constrained Model Selection and Cost-Sensitive Threshold Control for Explainable Diabetes Readmission Prediction},
  journal = {Advances in Precision Medicine},
  year = {2026},
  volume = {11},
  number = {7},
  pages = {176--202},
  doi = {10.26689/apm.v11i7.16183}
}
Kostenlos starten →